Levin Noam, Pato Aviad, Cafri Gal, Eisenberg Galit, Peretz Tamar, Margalit Alon, Lotem Michal, Gross Gideon
*Laboratory of Immunology, MIGAL-Galilee Research Institute, Kiryat Shmona †Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Jerusalem ‡Department of Immunology, Weizmann Institute of Science, Rehovot §Tel-Hai College, Upper Galilee, Israel.
J Immunother. 2017 Feb/Mar;40(2):39-50. doi: 10.1097/CJI.0000000000000150.
The interaction between the CD40 receptor on antigen-presenting cells (APCs) and its trimeric ligand on CD4 T cells is essential for the initiation and progression of the adaptive immune response. Here we undertook to endow CD40 with the capacity to trigger spontaneous APC activation through ligand-independent oligomerization. To this end we exploited the GCN4 yeast transcriptional activator, which contains a leucine zipper DNA-binding motif that induces homophilic interactions. We incorporated GCN4 variants forming homodimers, trimers, or tetramers at the intracellular domain of human and mouse CD40 and replaced the extracellular portion with peptide-β2m or other peptide tags. In parallel we examined similarly truncated CD40 monomers lacking a GCN4 motif. The oligomeric products appeared to arrange in high-molecular-weight aggregates and were considerably superior to the monomer in their ability to trigger nuclear factor kB signaling, substantiating the anticipated constitutively active (ca) phenotype. Cumulative results in human and mouse APC lines transfected with caCD40 mRNA revealed spontaneous upregulation of CD80, IL-1β, TNFα, IL-6, and IL-12, which could be further enhanced by caTLR4 mRNA. In mouse bone-marrow-derived dendritic cells caCD40 upregulated CD80, CD86, MHC-II, and IL-12 and in human monocyte-derived dendritic cells it elevated surface CD80, CD83 CD86, CCR7, and HLA-DR. Oligomeric products carrying the peptide-β2m extracellular portion could support MHC-I presentation of the linked peptide up to 4 days post-mRNA transfection. These findings demonstrate that the expression of a single caCD40 derivative in APCs can exert multiple immunostimulatory effects, offering a new powerful tool in the design of gene-based cancer vaccines.
抗原呈递细胞(APC)上的CD40受体与其在CD4 T细胞上的三聚体配体之间的相互作用对于适应性免疫反应的启动和进展至关重要。在此,我们致力于赋予CD40通过非配体依赖性寡聚化触发APC自发激活的能力。为此,我们利用了GCN4酵母转录激活因子,其含有诱导同源相互作用的亮氨酸拉链DNA结合基序。我们将形成同二聚体、三聚体或四聚体的GCN4变体整合到人及小鼠CD40的细胞内结构域,并将细胞外部分替换为肽-β2m或其他肽标签。同时,我们研究了缺乏GCN4基序的类似截短的CD40单体。寡聚产物似乎排列成高分子量聚集体,并且在触发核因子κB信号传导的能力方面明显优于单体,证实了预期的组成型激活(ca)表型。用caCD40 mRNA转染的人和小鼠APC系中的累积结果显示,CD80、IL-1β、TNFα、IL-6和IL-12自发上调,caTLR4 mRNA可进一步增强这种上调。在小鼠骨髓来源的树突状细胞中,caCD40上调了CD80、CD86、MHC-II和IL-12,在人单核细胞来源的树突状细胞中,它提高了表面CD80、CD83、CD86、CCR7和HLA-DR。携带肽-β2m细胞外部分的寡聚产物在mRNA转染后长达4天可以支持连接肽的MHC-I呈递。这些发现表明,在APC中表达单一的caCD40衍生物可以发挥多种免疫刺激作用,为基于基因的癌症疫苗设计提供了一种新的强大工具。